These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study. Brugarolas A; Lacave AJ; Ribas A; Miralles MT Eur J Cancer (1965); 1978 May; 14(5):501-5. PubMed ID: 348479 [No Abstract] [Full Text] [Related]
44. [Fiberoptic bronchoscopy-gold vapor laser treatment of bronchogenic carcinoma]. Deng WW Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):25-6, 63. PubMed ID: 2848635 [No Abstract] [Full Text] [Related]
45. Intensive chemotherapy of small cell bronchogenic carcinoma. Cohen MH; Creaven PJ; Fossieck BE; Broder LE; Selawry OS; Johnston AV; Williams CL; Minna JD Cancer Treat Rep; 1977; 61(3):349-54. PubMed ID: 194691 [TBL] [Abstract][Full Text] [Related]
46. [Intratumoral chemotherapy in the treatment of regional widespread pulmonary cancer]. Zvarych IuM; Shevchenko AI Klin Khir; 2003 Sep; (9):32-3. PubMed ID: 14663908 [TBL] [Abstract][Full Text] [Related]
47. Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide. Bergsagel DE; Jenkin RD; Pringle JF; White DM; Fetterly JC; Klaassen DJ; McDermot RS Cancer; 1972 Sep; 30(3):621-7. PubMed ID: 4342407 [No Abstract] [Full Text] [Related]
48. Adriamycin and adriamycin--DNA in inoperable bronchogenic carcinoma. A randomized study with cyclophosphamide vinblastine. Bosly A; Prignot J; Ledent C; Sokal G; Trouet A Eur J Cancer (1965); 1978 Jun; 14(6):639-44. PubMed ID: 658087 [No Abstract] [Full Text] [Related]
49. [Trials of synchronized attack drug therapy in bronchogenic carcinoma]. Seccia A; Scafuri L; Scognamillo A; Cocco G G Ital Chemioter; 1975; 22(1-2):63-6. PubMed ID: 1235355 [No Abstract] [Full Text] [Related]
50. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma. Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694 [No Abstract] [Full Text] [Related]
51. Combination chemotherapy and radiation therapy for small cell carcinoma. Holoye PY; Samuels ML; Lanzotti VJ; Smith T; Barkley HT JAMA; 1977 Mar; 237(12):1221-4. PubMed ID: 190427 [TBL] [Abstract][Full Text] [Related]
52. [Place of chemotherapy in the treatment of primary bronchial cancers]. Clément F Bronches; 1972; 22(3):176-89. PubMed ID: 4349927 [No Abstract] [Full Text] [Related]
53. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma. Alberto P Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321 [No Abstract] [Full Text] [Related]
55. [Combination chemotherapy for bronchogenic carcinoma based on cell type]. Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564 [TBL] [Abstract][Full Text] [Related]
56. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920 [TBL] [Abstract][Full Text] [Related]
59. Results of a E.O.R.T.C. Randomized trial of cyclophosphamide and radiotherapy in inoperable lung cancer: prognostic factors and treatment results. Byar D; Kenis Y; Van Andel JG; de Jong M; Laval P; Marion L; Couette JE; Longueville J Eur J Cancer (1965); 1978 Sep; 14(9):919-30. PubMed ID: 361416 [No Abstract] [Full Text] [Related]
60. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma. Holoye PY Exp Hematol; 1985; 13 Suppl 16():72-9. PubMed ID: 2985416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]